A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer
暂无分享，去创建一个
M. Sherman | A. Hezel | A. El-Khoueiry | A. Adjei | F. Braiteh | J. Stephenson | D. P. Leffingwell | P. Rajagopalan | N. Clendeninn | D. Richards | J. Miner | C. Becerra | L. Garbo | C. Iverson | Zancong Shen | L. Yeh | Sonny Gunawan | David M. Wilson | Kimberly Manhard | H. Krissel | Z. Shen